2-hydroxy-5-nitrobenzylthioguanosine has been researched along with n(6)-phenyladenosine in 1 studies
| Studies (2-hydroxy-5-nitrobenzylthioguanosine) | Trials (2-hydroxy-5-nitrobenzylthioguanosine) | Recent Studies (post-2010) (2-hydroxy-5-nitrobenzylthioguanosine) | Studies (n(6)-phenyladenosine) | Trials (n(6)-phenyladenosine) | Recent Studies (post-2010) (n(6)-phenyladenosine) |
|---|---|---|---|---|---|
| 11 | 0 | 0 | 28 | 0 | 6 |
| Protein | Taxonomy | 2-hydroxy-5-nitrobenzylthioguanosine (IC50) | n(6)-phenyladenosine (IC50) |
|---|---|---|---|
| neuropeptide Y receptor type 1 | Homo sapiens (human) | 7.826 | |
| neuropeptide Y receptor type 2 | Homo sapiens (human) | 4.729 | |
| Adenosine receptor A1 | Rattus norvegicus (Norway rat) | 0.0049 | |
| Adenosine receptor A2b | Rattus norvegicus (Norway rat) | 0.66 | |
| Adenosine receptor A2a | Rattus norvegicus (Norway rat) | 0.66 | |
| Adenosine receptor A1 | Gallus gallus (chicken) | 0.0046 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buolamwini, JK; Zhu, Z | 1 |
1 other study(ies) available for 2-hydroxy-5-nitrobenzylthioguanosine and n(6)-phenyladenosine
| Article | Year |
|---|---|
Constrained NBMPR analogue synthesis, pharmacophore mapping and 3D-QSAR modeling of equilibrative nucleoside transporter 1 (ENT1) inhibitory activity.
Topics: Drug Design; Equilibrative Nucleoside Transporter 1; Glycosides; Humans; K562 Cells; Models, Biological; Models, Molecular; Molecular Structure; Quantitative Structure-Activity Relationship; Static Electricity; Thioinosine | 2008 |